Insmed INSM 深 沪
等待开盘 10-06 09:30:00 美东时间
103.83
-7.290
-6.56%
华盛通- 最 高130.83
- 今 开105.50
- 成交量 536.35万股
- 最 低 101.69
- 昨 收 111.12
- 总市值 1245.96万
- 52周最高 212.75
- 市盈率 静 --
- 换手率 4469.56%
- 52周最低 90.39
- 委 比 15.95%
- 总股本 0.00亿
- 历史最高 212.75
- 量 比 1.84
- 振 幅 26.22%
- 历史最低 1.10
- 每 手 1
- 风险率 31.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Insmed Sees Sustained Gains With Inhaled Drug for Stressed Heart Functioning
Insmed reports 12-month TPIP extension data showing sustained efficacy and favorable safety in PAH ahead of Phase 3 PALM-PAH.
07-17 02:32
Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bio’s Lead Therapy
William Blair starts Zura Bio (NASDAQ: ZURA) at Outperform, citing tibulizumab's multibillion-dollar potential in autoimmune disease.
07-09 01:24
Why Is CoreWeave Stock Soaring Friday?
CRWV stock climbs 5% as CoreWeave gears up to join the Nasdaq-100. Get the latest price action, inclusion details, and analysis.
06-12 18:41
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
05-26 01:35
Insmed Drug Misses Primary Goal, Program Axed
Insmed halts HS program after CEDAR study miss; analysts cite trial challenges while focus shifts to Brinsupri and Arikayce growth drivers.
04-08 19:08
Insmed Lung Infection Therapy Data Impresses, Analyst Sees Approval Path
Insmed says Phase 3b Arikayce data show symptom and culture gains in lung infection patients, analyst backs approval.
03-24 00:24
Earnings Scheduled For February 19, 2026
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Why Is Insmed Stock Falling Thursday?
Insmed shares fall after brensocatib misses Phase 2b CRSsNP endpoints, prompting program discontinuation as analysts remain bullish on other assets.
2025-12-19 01:30
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
2025-10-31 01:40
长风药业：国产替代叠加需求爆发，有望在吸入式制剂领域复刻英伟达与比亚迪的投资逻辑与叙事模型
（来源：蚌埠新闻网） 转自：蚌埠新闻网 2025年9月26日，长风药业股份有限公司正式启动全球公开发售，计划发行约4119.8万股H股，发售价定为每股14.7...
2025-10-09 11:21
